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Background: Even though the classification of cancer tissue samples based on gene expression data has advanced
considerably in recent years, it faces great challenges to improve accuracy. One of the challenges is to establish an
effective method that can select a parsimonious set of relevant genes. So far, most methods for gene selection in
literature focus on screening individual or pairs of genes without considering the possible interactions among
genes. Here we introduce a new computational method named the Binary Matrix Shuffling Filter (BMSF). It not only
overcomes the difficulty associated with the search schemes of traditional wrapper methods and overfitting
problem in large dimensional search space but also takes potential gene interactions into account during gene
selection. This method, coupled with Support Vector Machine (SVM) for implementation, often selects very small
number of genes for easy model interpretability.
Results: We applied our method to 9 two-class gene expression datasets involving human cancers. During the
gene selection process, the set of genes to be kept in the model was recursively refined and repeatedly updated
according to the effect of a given gene on the contributions of other genes in reference to their usefulness in
cancer classification. The small number of informative genes selected from each dataset leads to significantly
improved leave-one-out (LOOCV) classification accuracy across all 9 datasets for multiple classifiers. Our method also
exhibits broad generalization in the genes selected since multiple commonly used classifiers achieved either
equivalent or much higher LOOCV accuracy than those reported in literature.
Conclusions: Evaluation of a gene’s contribution to binary cancer classification is better to be considered after
adjusting for the joint effect of a large number of other genes. A computationally efficient search scheme was
provided to perform effective search in the extensive feature space that includes possible interactions of many
genes. Performance of the algorithm applied to 9 datasets suggests that it is possible to improve the accuracy of
cancer classification by a big margin when joint effects of many genes are considered.Background
Classification of cancer tissue samples based on micro-
array expression data is of great interest in recent years.
This was driven by biomedical applications to differenti-
ate cancerous tissue samples from normal samples as
well as different tumor subtypes. Though many methods
have been recently developed, further improvement in
classification accuracy is needed before molecular meth-
ods can be used to replace laborious histological
approaches. An obvious challenge for effective classifica-
tion is that the number of samples is much smaller than* Correspondence: hwang@ksu.edu; zhmyuan@sina.com
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reproduction in any medium, provided the orthe number of available features. There are two directions
to tackle the challenge. Some studies focus on how to de-
sign or create better classifiers with a given sets of features.
Examples are SVM [1], Top Scoring Pair (TSP) [2], k-Top
Scoring Pair (k-TSP) [3], and Hyper-box Enclosure (HBE)
[4]. A common feature of these methods is that they de-
pend critically on prescreening of genes such as through
comparing the absolute value of a T-statistic. The other dir-
ection is to seek ways to reduce the dimensionality of the
feature space and select the informative genes for effective
classification with new or existing classifiers. Efforts in this
direction include, for example, Prediction Analysis of
Microarrays (PAM, [5]), individual-gene-ranking methods
by evaluating the discriminating power of classes (see [6,7],
and the references therein), redundant gene filteringLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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ter (BBF) [10].
Individual gene-ranking methods perform gene pre-
selection through a univariate criterion function to pro-
vide a list of top ranked genes. However, the combination
of top ranked genes through individual gene-ranking
may not produce a top ranked combination of genes be-
cause individual ranking tends to ignore the redundancy
and interaction among genes. As a result, such methods
tend to have low power when the co-regulation of mul-
tiple genes or pathways during tumor progression is not
fully utilized. An example is shown in Table 1 of this
paper, in which the combination of six genes selected
yields high accuracy for classification of the colon cancer
data [11]. However, two out of the six genes have
p-values greater than 0.9. These two genes have extremely
low chance to be selected by individual gene-ranking
methods. Recently, Chopra et al. [12] proposed to use
doublets made from gene pair combinations as inputs to
cancer classification algorithms. The rationale behind the
doublets is that biomolecular pathways may be stronger
biomarkers for cancer as compared to individual genes
[13]. It is shown by Chopra et al. [12] that upon using
doublets, classification accuracy of several classification
algorithms were consistently improved across different
datasets compared to the same algorithms with the same
number of single genes.
It is more realistic and promising to extend the doub-
lets method to include multiple genes instead of only
gene pairs since pathways often involve several crucial
genes. For example, it has been reported that colorectal
carcinoma is developed from the accumulation of gen-
etic alterations, including chromosomal instability, gene
mutations, and epigenetic abnormality after initiated by
inactivation of the adenomatous polyposis coli tumour-
suppressor pathway in a cell within the colon [14,15].
The doublet method can describe the co-regulation
patterns of two genes (either up-up, up-down, or
down-down) with simple operations such as summation,
difference, and multiplication. However, for a pathway
involving three or more genes, such simple operations
are not sufficient to describe the exponentiallyTable 1 Selected genes from original colon dataset after
screening by t-test







The paired t-test was conducted according to the method described in section
"Importance ordering and significance of the selected genes".increasing number of patterns. In such cases, unknown
and possibly complex interactions among genes will add
additional features to the already N-P hard problem due
to the small sample size and large number of features. If
all genes and their interactions at all levels (two-way and
higher-way interactions) were to be considered in the
search space, the dimension of the search space is ultra-
high. Consider the colon cancer microarray data [11] for
an example, the feature subset search space contains
22000 features when all interactions are included while
the sample size is only 62. The colon cancer data con-
tains the least number of genes among those we consid-
ered. The other cancer microarray datasets contain at
least 7000 genes and the sample size is mostly much less
than 100. Including interactions among genes essentially
makes the feature subset search space have infinite
dimension.
Available variable selection methods often fall into one
of the three categories: filtering approaches, wrapper
approaches, and embedded methods, where the latter
class combines advantages of filters and wrappers. A fil-
tering approach assesses the relevance of a feature subset
without consulting with a classification algorithm, mean-
while a wrapper approach searches the optimal feature
set that maximized the classification performance
defined in terms of an evaluation function (such as cross-
validation accuracy). It has been well accepted that
wrapper approaches tend to provide better classifica-
tion accuracy than the same algorithms with variable
selection through filtering approaches (see [16] and the
references therein). One limitation with the wrapper
methods is that the search of optimal feature subsets
for different classification algorithms needs to be con-
ducted separately. Consequently the feature subset
selected by one algorithm does not generalize well to
other algorithms [16,17]. Another limitation of the
traditional wrapper methods is that the estimation of
the evaluation function in feature subset selection may
cause an overfitting problem when the sample size is
small. Note that a sample size of 100 with less than
50 features is deemed small in [16]. The sample sizes
in the data setting of this article are extremely small
in presence of the near infinite dimensional feature
search space. Therefore, a simple application of trad-
itional wrapper methods will incur a serious overfitting
problem in current settings that leads to overly opti-
mistic evaluation of the function and poor classifica-
tion accuracy of the test data. A third limitation with
the wrapper methods is that they need almost prohibi-
tive computation by exhaustively searching through all
possible combinations of gene sets. Hill-climbing
(greedy search, or steepest ascent) and best-first search
are such examples. They are only applicable when the
number of features is small. Partial search schemes,
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ation, sequential floating backward elimination and
random search, were often employed. A drawback with
the partial search is that the algorithm may converge
to a locally optimal solution instead of the global
optimum. How to perform the search in the space of
feature subsets has been studied for many years. Seek-
ing effective searching schemes in wrapper methods
for data with a large number of features remains to be
an active topic. Consistent with our goal of consider-
ing gene interactions in the search space is a claim by
Cover and Campenhout [18] that even for multivariate
normally distributed features, no greedy search proced-
ure that selects one feature at a time can find the best
feature subset of a desired size; even an algorithm that
adds the best pair and removes the worst single feature
can fail.
Embedded methods use internal information of the clas-
sification model to perform feature selection. Support Vec-
tor Machine Recursive Feature Elimination (SVM-RFE),
known as an excellent feature ranking algorithm, is one of
the embedded methods. In SVM-RFE algorithm, the ob-
jective function J is half the L2 norm of the weight vector.
In linear kernel SVM, the weight vector can be calculated
explicitly. In each iteration, the elimination of the feature
with the least squared weight will cause the least effect on
J [19-21]. Therefore, the weight vector is adopted as rank-
ing criterion. To improve the efficiency of the algorithm,
more features can be eliminated at each step [22]. Re-
cently, Liu et al. [23] extended SVM-RFE to RBF kernel
based on Recursive Feature Elimination (SVM-RBF-RFE)
by expanding nonlinear RBF kernel into its Maclaurin
series to calculate the weight vector.
Ensemble methods are a class of popular methods that
combine the effort of both classifier building and feature se-
lection. An ensemble method uses multiple classifiers to
produce a learner system. Many mechanisms have been pro-
posed for the creation of ensemble of classifiers in the litera-
ture. These include using different subsets of training data
with a single learning technique, using different learning
methods, or using different training parameters with a single
learning method. One popular ensemble algorithm for data-
sets with a large number of features is the random subspace
method [24], which represents a class of learning ensembles
of weak classifiers to achieve good prediction accuracy. A
random subspace method generates a large number of weak
classifiers each trained on randomly chosen low dimensional
subspace of the original input space. The ensemble output is
obtained through majority voting or aggregation techniques
(cf. [25]). Random space search methods effectively reduce
the curse of dimensionality problem and are known to im-
prove weak classifiers. Random forest with the tree classifier,
one of the random subspace search methods, has been
demonstrated to have comparable performance to otherclassification methods including Diagonal Linear Discrimin-
ant Analysis (DLDA), K nearest neighbor (KNN), and SVM.
Open issues related to random subspace search methods in-
clude the conditions under which ensemble outperforms an
individual classifier and how to determine a suitable ensem-
ble size for a task with given computational requirements
in terms of memory size and CPU time [26]. Other en-
semble methods including bagging [27] which employs
majority voting over results from a large number of boot-
strap samples, and boosting [28-30] which construct clas-
sifiers on weighted versions of the training set which
depends on previous classification results. Bagging
changes the distribution of the data stochastically and
boosting changes the distribution of the data set adap-
tively based on the performance of previously created lear-
ners. Skurichina and Duin [31] demonstrated usefulness
of bagging, boosting and the random subspace method in
linear discriminant analysis. See [26] for a more detailed
review of different ensemble methods. An ensemble
combing bagging, boosting, rotation forest and random
subspace version of the same learning algorithm using a
voting methodology was also proposed in [26].
There are some unsettled challenges associated with
SVM-RFE and the random space search methods: (1) In
SVM-RFE and some of the random space search methods,
the number of variables to be selected or the subspace di-
mension size is often set to be a fixed known parameter
that requires the user to supply a value. The SVM-RFE
methods only provide a ranking of the features and rely
on the user to specify the number of features to be
selected. The weighted random subspace method by Li
and Zhao [25] only considered the number of variables to
be 10 in all their experiments. In practice, the number of
informative features is unknown and need to be well esti-
mated in order for the ensemble classifiers to have good
performance. When the number of features used in the
subspace ensemble is less than the true number that gen-
erated the response variable, the resulting classifiers may
not capture the pattern. When the number of features
used is more than the true one, the noisy features included
would degrade the performance of the classifiers. How to
reliably estimate the number of informative features remain
to be a challenging problem. (2) The SVM-RFE top ranked
genes do not generalize well to other algorithms. The top
ranked genes from SVM-RFE may have poor classification
performance when they are used with other classifiers. For
instance, we obtained the list of ranked genes using the
SVM-RFE algorithm (removing one feature at a time) on
several cancer datasets. Then we obtained the LOOCV ac-
curacy with the top k genes in each data set using the linear
discriminant classifier (LDA) and the Naïve Bayes classifier
(NB) for, k=2, . . ., 150 (see Figure 1). The LOOCV accuracy
of the LDA classifier using the top ranked genes provided
by SVM-RFE accuracy increases initially as the number of
Figure 1 Plot of LOOCV accuracy of LDA, NB, and SVM using k top ranked genes from SVM-RFE for k = 2, . . ., 150. The accuracy of SVM
in general increases as more genes are included in the model. The accuracies of LDA and NB do not show an increasing pattern suggesting that the
gene ranking by SVM-RFE is SVM specific and may not generalize well to NB or LDA. The plotted curves assume the number of genes is known (oracle
situation). Without knowing the number of genes to be used, additional variability will add to the LOOCV accuracy. The diamond-shaped points show
the LOOCV accuracy of the LDA, NB, and SVM classifiers using the genes selected by BMSF.
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when the number of genes is between 50 and 100. In many
cases, the accuracy falls below 70% for different cancer
microarray data sets. The NB classifier applied to the colon
cancer data even has an overall decreasing pattern for
LOOCV accuracy as the number of top ranked genes from
SVM-RFE increases.In this article, we present a hybrid method to overcome
some of the challenges mentioned above for ensemble and
wrapper methods in the high dimensional feature selec-
tion with small sample sizes. That is, we consider how to
avoid overfitting and provide effective search of inform-
ative genes in the infinite dimensional search space with
limited resource (storage and speed of model training and









CNS 7129 25(C) 9(D) [32]
Colon 2000 40(T) 22(N) [11]
DLBCL 7129 58(D) 19(F) [33]
GCM 16063 190(C) 90(N) [34]
Leukemia 7129 25(AML) 47(ALL) [35]
Lung 12533 150(A) 31(M) [36]
Prostate1 12600 52(T) 50(N) [37]
Prostate2 12625 38(T) 50(N) [38]
Prostate3 12626 24(T) 9(N) [39]
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search scheme to provide high classification accuracy for
multiple algorithms, and how to determine the number of
informative genes. We named our method Binary Matrix
Shuffling Filter (BMSF). BMSF is a data-driven guided
random search algorithm implemented through binary
matrix shuffling coupled with SVM to perform filtering.
The method introduces intermediate data matrices with
binary values to convert the high-dimensional feature
space search into the optimization problem of support
vector machine regression (SVR) with the response being
the Matthew’s correlation coefficient and predictors being
multiple factors each with two levels (see Section 3.1).
Extensive search of the large dimensional feature space in-
cluding gene interactions is made feasible by reducing the
number of models trained and exploiting predications
more often to take full advantage of SVR’s property of
being time-consuming in training yet fast in prediction.
As a result of less model training, the method smartly
avoids the overfitting problem in small sample size and
poor generalization drawback for the feature subset selec-
tion to other algorithms. The significance of our method
includes: (1) The gene selection process considers the dif-
ferentiating power of a gene conditional on the possibly
nonlinear effects of other gene combinations. This allows
complicated interactions among genes to be fully incorpo-
rated to reflect pathway changes during tumor progres-
sion. (2) BMSF often selects a relatively small number of
genes that can accurately classify samples. This helps to
achieve the goal of finding a minimal gene list to facilitate
the search for new diagnostic tools and follow up study.
(3) BMSF not only leads to improved LOOCV classifica-
tion accuracy of SVM that was wrapped with the variable
selection process, but also results in better performance
for multiple classifiers including Naive Bayes (NB), linear
discriminant analysis (LDA), quadratic discriminant ana-
lysis (QDA). (4) Using the genes selected by the BMSF,
SVM, LDA, and QDA reached or exceeded the highest
LOOCV accuracy reported in literature. This confirms
that allowing interactions among features in the search
space coupled with a manageable search scheme as in
BMSF not only respect natural underlying bio-molecular
reaction mechanisms but also provide better accuracy for
biomarker selection.Results
Here we present the performance of the proposed algo-
rithm on 9 benchmark binary class expression datasets
all related to human cancers, including central nervous
system, colorectal, diffuse large B-cell lymphoma,
leukemia, lung, and prostate tumors. The sample size
and number of genes in each dataset are summarized in
Table 2.Final list of Informative genes
As mentioned in the introduction, many classifiers and
feature selection methods preprocess the data by applying a
univariate test (such as a t-test) to reduce the number of
genes before conducting further refined procedures. The
preprocessing briefly assesses the main effect of one gene
without considering the effects of other genes. To be con-
sistent with the literature and make it easy for comparison,
we only report the selected genes after a preprocessing with
the t-test and then applying our algorithm on the genes
with p-value less than α=0.05. Table 3 summarizes the
selected genes, some of which are new while others can
also be found in the literature. For example, consider the
three informative genes found for the leukemia data.
X95735 (Zyxin) was found to play an important role in
differentiating acute myelogenous leukemia (AML) and
acute lymphoblastic leukemia (ALL) by multiple authors
[35,40-43]. Zyxin is a zinc-binding phosphoprotein that
concentrates along the actin cytoskeleton and at focal adhe-
sions that enable cells to adhere to the extracellular matrix
and at which protein complexes involved in signal trans-
duction assemble [44]. Y07604 was reported as one of
the top five genes with the highest selection frequency for
classification of the leukemia data in Yang et al. [43]. High
expression of the protein encoded by Y07604 is associated
with poor prognosis and advanced stages in myelodysplas-
tic syndrome which frequently transforms into AML [45].
D26156 was reported to be a discriminatory gene be-
tween AML and ALL in Golub et al. [35] and was also
among the top ranking genes reported in Broberg [40]
based on multiple gene ranking methods. Real time PCR
measurement of D26156 was highly expressed from
patients with AML [46]. The protein encoded by D26156
is a member of the large ATP-dependent chromatin re-
modeling complex SWI/SNF family of proteins, which
have helicase and ATPase activities and are thought to
regulate transcription of certain genes by altering the
chromatin structure around those genes [47]. In addition,
this protein can bind BRCA1, as well as regulate the
Table 3 Summary of selected genes
Dataset Number of genes Selected genes
CNS 3 J03507, U00968, Y00757
Colon 7 Z50753, H67764, H17434, R88740, R36977, R81170, U14631
DLBCL 6 K03430_at, M37815_cds1_at, X51688_at, X76534_at, Z70723_at, M16652_at
GCM 32 S82075_at, U35048_at, U61374_at, U87964_at, U95090_at, U97188_at, X14445_at, X92715_at,
M29610_at, M21642_at, M19267_s_at, M19878_at, Z50115_s_at, X93511_s_at, X56687_s_at,
AA256220_at, AA334630_at, AA362708_at, D30921_at, M54994_f_at, R10529_at, R29657_at,
W27827_at, W39573_at, Z49995_at-2, RC_AA100437_at, RC_AA210695_at, RC_AA252372_at,
RC_AA278134_at, RC_AA281769_s_at, RC_AA405698_at, RC_AA489009_at
Leukemia 3 X95735_at, Y07604_at, D26156_s_at
Lung 8 1779_s_at, 33246_at, 36354_at, 38221_at, 40363_r_at, 540_at, 631_g_at, 885_g_at
Prostate1 8 33614_at, 38322_at, 36627_at, 38041_at, 41303_r_at, 1846_at,930_at, 829_s_at
Prostate2 11 31673_s_at, 35099_at, 37821_at, 40038_at, 41077_at, 36030_at, 37209_g_at, 38983_at,
33928_r_at, 38832_r_at, 33188_at
Prostate3 2 39364_s_at, 40546_s_at
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reported in Medina et al. [48] that the protein encoded
by D26156 is a bona fide tumor suppressor and a major
factor in lung tumorigenesis. The accession number of
the genes for other datasets and their putative functions
are listed in the Additional file 1: Table S1.
Leave-one-out cross-validation accuracy
The Leave-One-Out Cross-Validation (LOOCV) method
was used to estimate the accuracy of classifiers. For each
sample in the dataset, we used the rest of the samples in
the dataset to serve as training data for model building
and prediction for the class of this sample. For classifiers
that have tuning parameters (such as SVM), the optimal
parameters were first estimated with 5-fold CV using
the training data and then used in the modeling. The
classification accuracy of each dataset is the ratio of the
number of the correctly classified samples to the total
number of samples in that dataset, i.e., (True Positives
+True Negatives)/total number of samples. To assess
the generality of the selected informative genes, we also
evaluate the performance of LDA, QDA, and NB using
the selected genes in addition to SVM in LOOCV accur-
acy. The results along with some methods published in
the recent literature are summarized in Figure 2 and the
numerical values (denoted as BMSF-SVM/LDA/QDA/NB)
are given in Additional file 1: Table S2.
Note that all methods in Additional file 1: Table S2
use all the samples in each data set to perform feature
selection. As pointed out by a reviewer, the feature selec-
tion needs to use the training data if the main purpose is
to estimate the generalization error for future samples.
In such case, which genes are selected and the number
of genes selected are not the focus of the study since
each training data in the LOOCV procedure leads to a
separate list of genes. In the end, there are as many lists
of genes as the sample size. These different lists of genesare not helpful when the purpose is to find informative
genes indicative of the cancer status for a general popu-
lation. As far as we know, all of the LOOCV accuracy
reported in the literature for these 9 data sets used all
the samples to select informative genes. We followed the
same routine so that our results can be compared to
those reported in the literature.
First, we consider the average accuracy for each al-
gorithm across all cancers. Using the informative genes
selected with our method, the performance of SVM
has significantly improved from average accuracy
91.19% to 97.69% across nine datasets. LDA and QDA
cannot be applied directly to high dimensional dataset
since they require estimation of the high dimensional
covariance matrices whose estimate is not accurate
with limited sample sizes. With the genes selected by
our method, BMSF-LDA and BMSF-QDA performed
very well with average accuracy 94.82% and 94.67%
across nine datasets. The top three methods with highest
average accuracy among all those in Additional file 1:
Table S2 are BMSF-SVM, BMSF-LDA and BMSF-QDA.
The k-TSP method used to give the best performance
among those reported in literature for these nine data-
sets. It has 2.66%, 2.81%, and 5.68% more classification
errors on average than BMSF-LDA, BMSF-QDA, and
BMSF-SVM, respectively.
For individual cancer dataset, the BMSF either outper-
forms or has comparable performance to the best result
reported in the literature. For the CNS data, it can be
seen from Figure 2 that BMSF-LDA and BMSF-QDA
have equivalent accuracy as k-TSP, which are slightly
higher than BMSF-NB and BMSF-SVM. The rest of the
classifiers have much lower accuracy. For the Colon
data, BMSF-SVM has much better performance than the
other algorithms. For the DLBCL data, BMSF-SVM have
comparable top performance to k-TSP and TSP, followed
by BMSF-LDA,SVM, BMSF-QDA, and sign-PAM that
Figure 2 Comparison with top performance results reported in literature for nine cancer datasets.
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classifiers with the BMSF selected variables have better
accuracy than those using PAM and TSP. In this case,
SVM also gives good result. For the Leukemia dataset,
BMSF -LDA, BMSF-SVM and SVM have the best accur-
acy followed by BMSF-QDA. For the Lung data, BMSF-
SVM gives the best accuracy and BMSF-NB, SVM,
sign-PAM, mul-PAM and k-TSP fall slightly below. For
the Prostate1 data, BMSF-SVM is ahead of the other algo-
rithms; BMSF-LDA and TSP have comparable perform-
ance that is slightly higher than BMSF-QDA; BMSF-NB is
not as good as the rest of the algorithms. For the Prostate2
data, the four algorithms using BMSF selected variables
obviously outperform the rest of the algorithms with a
big margin. BMSF-SVM, BMSF-LDA, BMSF-QDA and
BMSF-NB had accuracies 98.86%, 94.32%, 90.91% and
89.77%, respectively, while direct application of SVM
only gave an accuracy of 76.14% and the highest accur-
acy reported in the literature is 81.25%. For the Pros-
tate3 data, BMSF-NB/QDA/SVM and SVM all achieved
100% accuracy; BMSF-LDA, mul-PAM, k-TSP, and TSP
have equivalent performance.
Beyond accuracy comparison, we also report the number
of genes used in each classifier in Table 4. Excluding theTSP method that can only consider pairs, the number of
genes selected by our method is among the top two smal-
lest sets over all data.
Average of absolute correlation among genes
In general the average of absolute correlation (AAC)
among all genes in each dataset is not very high due
to the fact that the majority of genes contain a lot of
random noises. The genes retained after prescreening
with the t-test typically have higher AAC than that for
the entire set of genes. This is because many co-
regulated genes displaying changes during the cancer
progression were retained after the prescreening. Our
algorithm tends to select gene sets with low redun-
dancy. This can be seen in the top panel of Figure 3.
The AAC after the filtering steps (see Section 5.1) and
fine evaluation steps (see Section 5.2) is much smaller
than the AAC after the t-test for all but the Leukemia,
Lung, and Prostate3 datasets. The AAC for Leukemia
increased at the end of our algorithm compared to
that after the t-test. For the Lung and Prostate3 data-
sets, the AAC did not change much. Incidentally, these
three datasets are the only ones that the best LOOCV
accuracy is 100% and there are other algorithms that
Figure 3 Average of absolute correlation (AAC) at each stage and its relationship with NB, SVM. The top panel gives the AAC for each
dataset. ‘Original’ refers to the entire dataset; ‘filtering’ refers to the stage after the procedures in Section 5.1; ‘Detailed evaluation’ refers to the
stage at the end of Section 5.2. The bottom panels show the relationship between the AAC on the original dataset with NB, BMSF-NB, SVM, and
BMSF-SVM classifiers. The original AAC appears to be reversely related to the accuracy of NB. The relationship of the original AAC with SVM is not
obvious. BMSF-NB and BMSF-SVM are much less influenced by the original AAC.
Table 4 Number of genes used in the classifiers for gene-expression datasets
Method CNS Colon DLBCL GCM Leukemia Lung Prostate1 Prostate2 Prostate3
TSP* 2 2 2 2 2 2 2 2 2
k-TSP* 10 2 2 10 18 10 2 18 2
SVM/NB ‡ 7129 2000 7129 16063 7129 12533 12600 12625 12626
PAM* 4 15 17 47 2296 9 47 13 701
Sumdiff/ mul/sign –PAM† 286 80 286 642 286 502 504 506 506
HBEЅ - - 6 - 4 - 10 - -
BBF-SVMÞ - 20 5 - - - 13 - -
Random forest (GeneSrF) 11 3 3 186 4 12 2 4 3
BMSF-SVM/NB/ LDA/QDAϒ 3 7 6 32 3 8 8 11 2
*Results obtained in Tan et al. [3] †Results obtained in Chopra et al. [12].
ÞResults obtained in Zhang and Deng [10] ЅResults obtained in Dagliyan et al. [4] ‡ Results obtained using all genes.
ϒRefers to each of the classifiers using our selected genes.
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does.
The bottom 2 panels of Figure 3 shows the relation-
ship between the AAC in the original datasets and NB,
SVM classifiers. In can be seen that the LOOCV accur-
acy of NB tends to be lower for datasets with higher ori-
ginal AAC. BMSF-NB is not as influenced by the
original AAC on accuracy as the NB. For the SVM clas-
sifier, original AAC is related to its performance and
there may be other factors affecting its performance. Re-
gardless of the magnitude of the original AAC, BMSF-
SVM produced consistently much better results.
Variability of results and joint effects of genes selected
from different runs of BMSF
Even though we did gene prescreening with t-test for
consistency with most methods in the literature, our re-
sult indicated that the prescreening was not necessary.
Figure 4 depicts the changing pattern in the number of
genes and the corresponding best MCC values at each
round of filtering steps in Sections 5.1 - 5.2. The second
and third columns correspond to the direct application
of our method on the colon cancer data, while the lastFigure 4 The change in the number of selected genes in each round.two columns correspond to the case with prescreening
via t-test. Even though the prescreening with the t-test
can save some time by drastically reducing the number
of genes at the beginning, it did not result in better
MCC values. Further fine evaluation with the procedure
in Section 5.2 led to a final list of 7 genes with LOOCV
accuracy 95.16% for the case with prescreening (Table 5)
and 6 genes with LOOCV accuracy 98.39% for the direct
application (Table 1). Genes T48041, M19311, X57206
and T57882 deemed unimportant by the univariate t-
test were among the final list of informative genes that
gave excellent LOOCV classification accuracy. This sug-
gests that the synergistic effects of these genes gave
more differentiating power than their individual effect.
The list of informative genes may be different in separ-
ate runs of our algorithm. This is because the random
matrix X generated in Section 5.1 may contain different
combinations of genes to be included for filtering. This,
however, should not significantly affect the accuracy of
the algorithm as there are several rounds of random
matrix generation and filtering to include as many com-
binations as possible. To support this argument, we
obtained 3 lists of informative genes for the LeukemiaThe values labeled are the best MCC.
Table 5 Selected genes from Colon dataset after
screening by t-test








The paired t-test was conducted according to the method described in section
"Importance ordering and significance of the selected genes".
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average accuracies are reported in Table 6. The three
lists of informative genes are totally different but the
LOOCV accuracies are very close suggesting that this
dataset has high redundancy. Biological interpretation of
such phenomenon would be that the selected genes are
not the only genes that have gone through changes dur-
ing cancer progression. Two lists of the genes could each
be a partial list of all genes showing differences between
the cancer statuses. On the other hand, our algorithm is
meant to select a parsimonious set of genes to achieve
high LOOCV classification accuracy. The selection
process is not designed to exhaustively find all genes
that exhibit difference for the two categories.
From a biological point of view, it might be interesting
to know whether the combination of the gene lists from
different runs can produce similar classification accur-
acy. Studying this can also infer the stability of BMSF
algorithms in terms of commonly selected genes in
different runs, and the joint effects of the genes on
classification accuracy. As an example, we considered
multiple runs of BMSF-SVM on the leukemia data.
We performed 30 runs (see Additional file 1: Table S3)
and randomly choose the results from k runs, where
k = 1, 2,. . ., 10, 15, 20, 25 is the union size. The in-
formative genes from the k runs are combined to
make a new list of informative genes and LOOCV
classification with this combined list of genes is con-
ducted. This procedure of random selection of k runs
and classification was repeated 30 times to assess the
results of the joint effect. As the union size increases,
the size of the combined list of genes increases. The
average LOOCV accuracy from the 30 randomTable 6 Results from three runs of the leukemia dataset
Run Selected genes LOOCV accuracy
1 X95735_at, Y07604_at, D26156_s_at 98.61
2 U82759_at, X95735_at, Y07604_at 97.22
3 M23197_at, U77604_at, M28170_at 100selections of single run is 98.52% with standard devi-
ation 0.96%. Thirty random selections of two runs
yield an average accuracy 99.54% with standard devi-
ation 0.76%. For 30 random selections of three runs,
the average accuracy using the combined genes from
three runs is 99.72% with standard deviation 0.67%.
For combined genes from more than four runs, the
average accuracy from 30 random selections is at least
99.91% with standard deviation less than 0.35%. The
results are summarized in Figure 5. The left plot in
Figure 5 gives the average LOOCV accuracy from 30
classifications using the 30 combined lists from ran-
dom selections of k runs. The standard errors are indi-
cated with the error bars. The right plot in Figure 5
gives the number of genes in the combined list as a
function of the union size k. The error bars in the
right plot gives the standard deviation from the 30
random selections. In summary, as the union size k
increases, the average accuracy increases and the
standard deviation of the accuracy decreases.
Comparison with 11 other variable selection methods
from RankGene and mRMR
To compare with other variable selection methods, we
choose variables with BMSF and 11 other variable se-
lection criteria available through RankGene at http://
genomics10.bu.edu/yangsu/rankgene/ and mRMR at
http://penglab.janelia.org/proj/mRMR/. RankGene pro-
vides eight ranking criteria including t-statistic, twoing
rule, information gain, gini index, max minority, sum
minority, sum of variances, and one-dimensional sup-
port vector machine. These criteria rank genes based
on their capability to distinguish between the classes.
The user is required to specify the number of genes to
be selected. mRMR conducts minimum redundancy
maximum relevance feature selection [8,17]. MID and
MIQ are two versions of mRMR highly recommended
by Peng et al. [17] and Ding and Peng [8]. The mRMR
can be used alone with a pre-specified number of vari-
ables to select or used with a classification algorithm
to choose the set of variables that minimize cross-
validation error.
MID and MIQ discretize the expression data into
intervals for both noise reduction and ease of estimation
of the mutual information. It has been reported in Ding
and Peng [8] that discretization leads to better classifica-
tion accuracy in mRMR than directly classifying the con-
tinuous expression data.
Different discretization schemes were reported to
give consistent results ([8]; http://penglab.janelia.org/
proj/mRMR/FAQ_mrmr.htm#Q5.3) when the expres-
sion values are transformed into 2 or 3 states by
comparing to μ±kσ for k ranges from 0.5 to 2, where
μ and σ are gene specific mean and standard
Figure 5 Joint effect of informative genes from multiple runs of the leukemia dataset. The left panel gives the LOOCV accuracy +/−
standard error from 30 runs using the combined list of genes. The right panel gives the number of genes in the combined list +/− standard
deviation from 30 runs. In both plots, the number of lists being combined is in the horizontal axis.
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ments such that the expression values greater than
μ+σ were discretized into state 1; values between μ-σ
and μ+σ are transformed to state 0; and values less
than μ-σ are transformed to state −1.
As RankGene does not provide a list of the informative
genes as BMSF and mRMR do, we consider to base our
comparisons on the LOOCV classification accuracy of
four algorithms (LDA, QDA, SVM, NB) using a pre-
specified number of genes selected from each criterion.
The error rate of mRMR tends to decrease as the num-
ber of genes increases [8,17]. Though BMSF and mRMR
with a classification algorithm both report a list of in-
formative genes, the numbers of genes are different.
mRMR tends to need more genes to have low error
rates. We set the number of genes for RankGene and
mRMR to be the number selected according to BMSF
on each of the nine cancer datasets. This allows us to
examine if the space of informative genes generated by
BMSF can be more easily classified than those generated
by mRMR or RankGene.The LOOCV accuracy for each of the four classification
algorithms (LDA, QDA, SVM, and NB) is presented in
the dotplot in Figure 6 (the numerical accuracy is in the
Additional file 1: Table S4). In the plot, the coordinate of a
point in the horizontal axis indicates the accuracy. A point
located to the right represents higher accuracy than a
point located to the left. In most of the cases, the algo-
rithms with variables selected by BMSF reach the highest
LOOCV accuracy. An explanation that BMSF outper-
forms mRMR is that mRMR criteria maximize the average
of all mutual information values between individual vari-
able and class and minimize the average mutual informa-
tion between two feature variables. If one variable is
selected at a time in incremental search, it is shown in
Peng et al. [17] that mRMR is equivalent to maximizing
the dependency between the features and the target class
(Max-Dependency). In reality, however, multiple variables
may be selected at the same time. In such case, joint
effects among multiple variables are not taken into ac-
count in mRMR. As a result, the list of selected variables
for any pre-specified number is not the most efficient
Figure 6 Comparison of different variable selection methods for the same classification algorithm. For each of the classification
algorithms (LDA, QDA, SVM, NB), identical number of genes are selected for each cancer dataset by BMSF and 11 other variable selection criteria
(the number of genes used is according to BMSF). The LOOCV accuracy is presented in the dotplot, in which the coordinate of a point in the
horizontal axis indicates the accuracy. A point located to the right represents higher accuracy than a point located to the left. In most of the
cases, the algorithms with variables selected by BMSF reach the highest LOOCV accuracy. For the GCM data, the variables selected by the eight
criteria from RankGene and MaxRel cannot perform QDA due to rank deficiency. So the average accuracy for QDA is calculated over the other
datasets for fair comparison.
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allow multiple variables to be selected at a time. This is
the case in our comparison.
It has been a common belief that a wrapper type fea-
ture selector can yield high classification accuracy for a
particular classifier and less generalization of the selected
variables on other classifiers. BMSF does not have such
limitation as the superiority of BMSF is not restricted to
the SVM that was wrapped with the algorithm for vari-
able selection. For all four classification algorithms we
considered (LDA, QDA, SVM, and NB), BMSF consist-
ently outperforms the other variable selection criteria on
each cancer data. The variables selected by BMSF yield
comparable relative performance for different classifiers.
This suggests that BMSF has the combined high accuracy
property of wrapper feature selectors and generality
property of filter type variable selectors.Comparison with random forest and SVM-RFE
In this subsection, we report comparison with the random
forest and SVM-RFE algorithms. We apply the SVM-RFE
with linear kernel. The algorithm starts with all the features
and eliminates one feature with the least squared weight at
each step until all the features are ranked. In a consistent
way to the treatment by [21] for application of SVM-RFE,
the original datasets are normalized by subtracting the
mean of the corresponding gene vector from each gene’s
expression data and then dividing by the corresponding
standard deviation.
SVM-RFE does not perform feature selection. Instead, it
only provides a list of ranked genes and the user need to
decide the number of genes to be selected. For this reason,
we cannot do a general fair comparison with it because our
method decides the number of genes to be selected. So we
only report a brief comparison, in which the SVM-RFE was
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obtained. We then plotted the LOOCV accuracy of LDA,
NB, and SVM classifiers using k top ranked genes from
SVM-RFE for k = 2, . . ., 150. The accuracy of SVM in gen-
eral increases as more genes are included in the model. The
accuracies of LDA and NB may fluctuate drastically or de-
crease as the number of genes increases. This suggests that
the gene ranking by SVM-RFE is SVM specific and may
not generalize well to NB or LDA. The plotted accuracy
curve is an oracle situation which assumes the number of
genes is a known priori. Without knowing the number of
genes to be used, additional variability will add to the
LOOCV accuracy. For convenience of comparison, the
LOOCV accuracy of the LDA, NB, and SVM classifiers
using the genes selected by BMSF are shown in the plot
with diamond-shaped points. The horizontal coordinates of
the points are set to be the number of genes selected by
BMSF. At each point location, the value on the curve of the
same color as the diamond point is the SVM-RFE accuracy
if SVM-RFE uses the same number of genes as BMSF.
These values are given in Additional file 1: Table S4. With
the same number of genes as BMSF, the QDA classifier
yielded comparable average accuracy for SVM-RFE and
BMSF; the SVM and NB classifiers had less average accur-
acy with the SVM-RFE genes than with the BMSF genes;
the LDA classifier had slightly better accuracy with the
SVM-RFE genes than with the BMSF genes. We emphasize
that the users are not recommended to interpret the results
discussed here strictly since in practice it is necessary to es-
timate the number of genes in order to use the SVM-RFE
which will lead to additional variability on the results.
We also compare with the random forest gene selection
algorithm GeneSrF provided by Diaz-Uriarte [49]. GeneSrF
was first applied to each dataset to select genes followed by
an application of LDA, QDA, NB, and SVM classifiers
using the selected genes with LOOCV. Since the GeneSrF
algorithm also automatically determines the number of
genes to be selected, we can compare BSMF and GeneSrF
on a fair basis. The results are also reported in AdditionalTable 7 Average and standard deviation of 10-fold CV accura
BMSF- SVM GeneSrF- SVM BMSF- NB GeneSrF- N
CNS 94.11(1.38) 88.23(0) 92.05(2.79) 91.17(0)
Colon 94.35(2.04) 78.22(2.18) 87.41(1.98) 86.93(1.93)
DLBCL 98.57(1.29) 88.44(2.48) 88.96(0.68) 88.57(0.54)
GCM 98.07(0.61) 92.07(0.9) 87.42(0.76) 84.17(0.24)
Leukemia 98.33(0.58) 96.66(0.97) 96.25(0.93) 94.58(0.43)
Lung 99.11(0.64) 98.95(0.4) 98.39(0.31) 98.34(0)
Pros1 96.76(0.8) 92.64(1.24) 89.6(0.82) 93.33(0.62)
Pros2 97.38(1.2) 83.75(2.27) 90(1.17) 85.11(1.46)
Pros3 98.48(1.59) 93.93(2.47) 99.69(0.95) 99.69(0.95)
BMSF and random forest (GeneSrF) are used for gene selection and SVM, NB, LDA,
test data.file 1: Table S4. The LDA classifier with the GeneSrF
selected genes has lower accuracy than the same classifier
used with the BMSF selected genes for 8 out of the 9 data-
sets. The exception is the Lung cancer data, for which the
BMSF and GeneSrF genes have comparable performance.
The average accuracy of the LDA classifier over the 9 data-
sets with BMSF genes is 94.82, while that for the GeneSrF
genes is 88.23. Similarly, the QDA and SVM classifiers
show better accuracy with the BMSF selected genes than
with the GeneSrF selected genes for most of the datasets.
The NB classifier showed comparable performance for the
BMSF and GeneSrF genes. These results are expected since
it is reported in Díaz-Uriarte and Alvarez de Andre’s 2006
that the random forests feature selection has comparable
performance to KNN and SVM. From our earlier compari-
son in Section 2.2 and Additional file 1: Table S2, we know
that BMSF outperforms SVM in most of the datasets. In
terms of the number of genes selected from an entire data-
set, GeneSrF reported less numbers for 5 of the datasets
than BMSF and both GeneSrF and BMSF selected no more
than 11 genes in these 5 datasets. In the remaining 4 data-
sets, GeneSrF selected more genes than BMSF. In particu-
lar, GeneSrF selected 186 genes while BMSF only selected
32 genes for the GCM data.
Upon the request of a reviewer, we also conducted com-
parison with repeated 10-fold cross validation. SVM-RFE is
excluded from the comparison since it does not determine
the number of genes. We compare the gene selection using
the BMSF and random forest by examining at the average
accuracy from multiple runs. For each random partition of
the data into 10-folds, 9 of the subsets are used as trainning
and the rest is used as the test data. BMSF and random for-
est (GeneSrF) are used for gene selection and SVM, NB,
LDA, QDA are used to build model with the training data
and predict the class of the test data. The accuracy from
each run of 10-fold CV is the proportion of correctly classi-
fied samples. We conducted 10 random partitions and
reported the mean and standard deviation of the 10-fold
CV accuracy from the 10 runs in Table 7. The results showcy from 10 runs
B BMSF- LDA GeneSrF- LDA BMSF- QDA GeneSrF- QDA
96.47(1.86) 83.23(3.93) 95.88(2.05) NA(NA)
87.41(1.48) 81.45(0.85) 89.51(1.9) 81.12(1.08)
96.23(0.41) 85.71(1.36) 94.15(1.1) 90(0.62)
91.14(0.66) 77.53(1.41) 90.25(0.93) NA(NA)
98.33(0.58) 93.19(0.43) 97.63(0.67) 94.58(0.78)
97.79(0.26) 98.34(0) 97.56(0.46) 98.34(0.26)
95.49(0.5) 90.98(1.01) 93.23(0.85) 91.56(0.68)
95.34(1.13) 85.45(0.71) 90.11(2.27) 83.63(1.09)
96.66(0.95) 93.93(0) 100(0) 96.66(1.72)
QDA are used to build model with the training data and predict the class of
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That is, the NB classifier using the BMSF has comparable
performance to that using GeneSrF selected genes. The
SVM and LDA classifiers with the BMSF selected genes
show much better performance than the same classifiers
using the GeneSrF selected genes. The QDA classifier with
the genes selected by BMSF has only slightly better results
than those selected by the GeneSrF.
Discussion
In this article, we proposed a new variable selection al-
gorithm BMSF that can select a small set of feature vari-
ables taking into account variable interactions to provide
highly accurate classification of the samples. The BMSF
method automatically conducts multiple rounds of filter-
ing and guided random search in the large feature subset
space and reports the final list of informative genes.
Though the variable selection process is wrapped with
SVM, the variables selected have general applicability to
multiple classification algorithms. SVM, LDA, QDA and
NB achieved superior LOOCV classification accuracy
with the selected variables from BMSF compared to 11
other variable selection criteria.
Different runs of BMSF may produce different lists of
informative genes. This phenomenon corresponds to the
fact that there are many possible prognostic genes. Our
goal is to find a minimal set of such genes that the com-
bination of them can well differentiate the cancer status
of the patients. Additional genes that are important for
sample classification can be obtained by carrying out
multiple runs of BMSF. For example, the U82759_at
selected from the second run of BMSF on the Leukemia
data encode HoxA9 (an Oncogene) that has a higher
level of expression in the samples from AML patients
than in the ALL patients [4]; the M23197_at gene
selected on the third run encodes CD33 antigen (differ-
entiation antigen) that is a membrane protein. CD33
has been reported to be a target for antibody-based anti-
leukaemic therapies as about 85%-90% of acute AML
cases are considered to be CD33 positive [50]. Conse-
quently, the resulting genes found from different runs
can be combined to provide a larger gene set signature.
Our experiments showed that the joint effects of the
genes from different runs typically increase the classifi-
cation accuracy.
It may be interesting to combine multiple variable se-
lection methods for better results. We comment that
BMSF can be used along with other methods as long as
the operation does not violate the principle of each
method. Consider Prediction Analysis of Microarrays
(PAM) by Tibshirani et al. [5] for an example. PAM is
not a classification algorithm alone. Instead, it performs
both variable selection and classification. A thresholding
parameter Δ needs to be estimated with cross-validation.Each parameter value Δ corresponds to a set of genes
selected for classification. If we apply PAM to each can-
cer dataset with the variables already selected by BMSF,
PAM would conduct variable selection again using all
samples within the subset of genes selected. This violates
the principle of PAM when only a small number of vari-
ables remain in the model because PAM employs the
thresholding idea to identify sparse signals out of a large
amount of noise (the test statistic value from each of a
large number of irrelevant variables corresponds to noise
and those from the few important variables are the sig-
nals; after variable selection by BMSF, the total number
of variables may not be large enough for the threshold-
ing idea to be legitimate). However, PAM may be applied
first to the original dataset since it tends to select many
more variables than BMSF. For example, the PAM appli-
cation in Leukemia dataset with the best Δ value yields a
model with more than 1000 variables. In such a case,
BMSF can still be applied to further reduce the number
of variables.
As with all feature selection results in microarray data,
the variables selected may or may not be a subset of can-
cer progression signature. Future validation of clinical
relevance of the selected genes through multiple external
cancer cohorts composes another line of work (see for
example [51-53]). They mainly address how to assess a
gene set signature’s prognostic value of a predefined size
relative to random gene sets. Boutros et al. [51] also pre-
sented a nonlinear Steepest Gradient Descent (greedy
forward selection) algorithm to identify prognostic gene
signatures from their 158-gene RT-PCR training dataset
of 147 patients. As is discussed in the introduction the
greedy search strategy with wrapper method is not tract-
able in current setting with high dimensional feature
space. Our work in this article provides a useful tool in
this regard.
Currently, this software was only implemented to per-
form two-class classification. In recent years, SVM has
been extended to perform multi-class classification and
regression. Further directions along this line can consider
extending the method to perform variables selection
when there are multiple classes or when the response
variable is continuous. We anticipate such extension to
be very helpful to improve the accuracy of multi-class
cancer classification and genome wide association study.
Conclusions
In summary, considering the discriminating power of a
gene after adjusting for the joint effect of many other
genes and their possible interactions can improve the
classification accuracy. We provided an effective algo-
rithm BMSF to carry out the search of important vari-
ables in the high dimensional feature space allowing
interactions of a large number of genes. The algorithm
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selected genes that renders high classification accuracy
for multiple classifiers. Our method not only overcomes
the difficulty associated with the search schemes of trad-
itional wrapper methods in large dimensional search
space but also has good generality for the genes selected.
This is confirmed by testing our method on the 9 bench-
mark binary class gene expression datasets all related to
human cancers.
Methods
Consider gene expression data with G genes from N tissue
samples. Denote the G genes as {g1, g2, . . ., gG}, and the N
tissue samples as {t1, t2, . . ., tN}. The objective is to assign
a class label for each tissue sample ti based on the
observed expression data matrix D from all genes. D is a
NxG matrix with the ith column represents the expression
values for gene gi from all tissue samples, and j
th row
represents the expression values for all genes from tissue j.
G is typically much larger than N, especially with high
density microarrays. In this study, we concentrate on the
two-class case, in which one class may be cancerous
tumor and the other class is normal, or the two classes
may refer to cancer subclasses such as different stages of a
cancer. Denote the two classes as positive (+) and negative
(−). The variable selection process seeks to identify the
genes such that the diagnosis of a tissue can be performed
via modeling the expression data of these genes, i.e., corre-
sponding columns of the matrix D. It has reached consen-
sus that not all genes are necessary to build a good
diagnosis classifier; and classifiers with less number of
genes but with equivalent or better accuracy is preferred
for ease of interpretation and further study of the marker
genes.
Fast filtering
First round of filtering
Since the modeled effect of one gene’s interaction with
other genes may change as the members of a gene set
vary, we perform multiple rounds of filtering to exclude
the large number of irrelevant genes. Before filtering, we
perform a 5-fold cross-validation (CV) to predict the
class labels using all genes and record the initial Matthew’s
correlation coefficient (MCC) defined as follows [54]:
Ø ¼ TPTN  FP  FNﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TPþFNð Þ TNþFPð Þ TPþFPð Þ TNþFNð Þp
where TP is the number of true positives, TN the number
of true negatives, FP the number of false positives and FN
the number of false negatives. If any of the four sums in
the denominator is zero, the MCC value Ø is set to zero
since the numerator is zero. The values of MCC is in the
range of [-1, 1] with value 1 indicating a perfect predictionand 0 an average random prediction. MCC is used instead
of the accuracy defined as the proportion of correctly clas-
sified subjects because MCC is more stable even if the
classes are of very different sizes. Denote this initial MCC
value as μ0.
Steps 1 – 3 below constitute the first round of
filtering.
Step 1 Specify genes to be included to perform guided
random search. As is known, tumor
development typically undergoes through a
complicated process that involve many genes.
To describe the combination of gene sets to be
considered for modeling, we generate a matrix X
with dimensions KxG with entries being either 1
or 0, representing whether the gene in that
column is included in the modeling or not. We
take K to be a large even number such as 500,
400, etc. The columns of X were generated by
permuting the entries of a K-dimensional vector
that contains K/2 ones and K/2 zeros. That is,
there are equal numbers of ones and zeros in
each column of X such that the same gene is
included in the modeling K/2 times and
excluded from the modeling K/2 times. Different
columns of X are different random permutations
of the K-dimensional vector. Each row of X is a
G-dimensional vector with value 1 representing
inclusion of the genes designated by
corresponding columns, and 0 representing
exclusion of the genes in corresponding
columns. Each row of X defines a gene set to be
considered for model training in the next step.
Different rows of X give different gene sets
formed through including a combination of a
random number of genes. For convenience, we
call X the inclusion scheme matrix.
Step 2 Evaluation of gene set contributions. For i=1, . . .,
K, denote the number of ones in the ith row of
X as pi and the locations of these ones in the
vector as li1, li2, . . ., lipi. The values of pi may
be different for different rows. The expression
data from genes gli1, gli2, . . ., glipi and the class
information of all subjects will be used in
cross-validation. We consider 5-fold CV of the
subjects using SVM, in which the subjects are
partitioned into five folds via stratified sampling
and the expression data and class labels from
four folds of the subjects are employed to train
the SVM model. The obtained model is then
applied to predict the class label for the
remaining one-fold of the subjects. After
prediction is carried out for each fold, we
calculate the Matthews correlation coefficient
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operation for i=1, . . ., K. The obtained MCC
values for all rows give us an initial idea of the
contribution from each of the randomly formed
gene set. Denote the vector of MCC values
calculated for all rows of X as Ø0.
Step 3 Assess individual gene’s contribution after
adjusting for contributions from other genes. A
gene may be related to the cancer status on its
own or through its interaction with other genes.
To assess the relative contribution of gene gi
taking into account of its possible interaction
with other genes, we compare the two cross-
validated prediction performances, one with the
gene included and one with the gene excluded
from a gene set. We consider the gene sets
defined in the inclusion scheme matrix X. For
the ith gene, this is performed as follows.1) Obtain matrix Xi by changing all the ones in i
th
column of X to zero and all the zeros in that column
to one while keeping the remaining columns of X
unchanged.
2) Train a SVM regression model m0 using Ø0 as the
response vector and X as the design matrix for
independent variables.
3) Predict the value of the response variable for each
row of Xi. Denote the K-dimensional vector of all
predicted response values as Ø1.
4) Form paired data Z0 and Zi, each of K dimension.
The kth entry z0k of Z0 and zik of Zi are defined as;
z0k ¼

k thvalue of Øo if χki ¼ 0
k thvalue of Øi if χki ¼ 1;
zik ¼

kthvalue of Øo if χki ¼ 1
k thvalue of Øi if χki ¼ 0;
where xki is the entry at the k
th row and ith column
of X. In other words, Z0 collects all those Ø0 and Ø1
entries such that the ith gene is excluded in the
modeling. Zi, on the other hand, collects all those Ø0
and Ø1 entries such that the i
th gene is included in
the modeling. The entries of Z0 and Zi are arranged
in the same order as the rows of X. Such
arrangement assures that the Z0 and Zi entries are
paired in the sense that except for the difference of
inclusion or exclusion of the ith gene, the conditions
of all other genes are held identical. Comparing Z0
and Zi would give us an idea of how significant the
ith gene contributes to explain the variations in the
class prediction performance conditional on various
combinations of other genes included in the model.
5) Calculate the average value of entries in Z0 and Zi
and denote them as z0 and zi, respectively. If z0 > zi,then excluding the ith gene tend to give better class
prediction performance measured by MCC. For
crude filtering at this stage, we permanently remove
the ith gene from further modeling if z0 > zi holds.
Perform 1) – 5) for all genes by letting i=1, 2, . . ., G.
This finishes one round of filtering.
We comment that only one cross-validated training is
performed for each row of the X matrix in the entire
first round filtering. The total number of training is K.
For each Xi, the trained SVM model is used for predic-
tion K times. After all Xi , i=1, 2, . . ., G, are considered,
the total number of predictions is in the order of KG.
This fully makes use of the advantage of the SVM that is
much faster in prediction than training.
Another comment we make is about the number of
columns in the inclusion scheme matrix X. In Step 1,
even though each row of the inclusion scheme matrix X
includes G/2 features on average, we did not use these
G/2 features alone to eliminate features. A gene included
in a row that does not contribute to the cancer status
variation with genes in that row may contribute through
interaction with genes not included in this row. That is,
a gene in one gene set may not show marginal or inter-
action effect but it may have strong interaction effect
with genes in another gene set. Therefore, we do not
eliminate features based on one random subspace. In-
stead, different rows of the inclusion scheme matrix X
include different gene sets (each of size G/2 on average).
The feature elimination is done by considering the effect
of a feature in different feature sets in Step 3. When all
the rows of matrix X are used in the evaluation of the ef-
fect of a single gene in Step 3, many gene combinations
are considered such that all G genes are included (in-
stead of G/2 genes). In classical ensemble methods, the
elimination of a feature is only based on the model with
the features included in the subspace that the ensemble
classifier is built. In such case, a feature could be elimi-
nated by mistake if the important feature combination
including this feature is not in the subspace. Our com-
plicated way of filtering hopefully could reduce the
chance of mistakenly eliminating an important feature.
The price to pay for taking into consideration of all G
features in evaluation of a single feature is the computa-
tional challenge with a large number of features specified
by each row of X. This, however, is not a concern with
the LIBSVM because LIBSVM is fast when there are a
large number of features and small sample size (LIBSVM
is slow when the number of features is small and the
sample size is large).
Further rounds of filtering
Our experience tells that roughly about half of the genes
are excluded after the first round filtering. Let G1 be the
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ing. Now we consider using only the expression data for
these G1 genes and the class labels in cross validation
with SVM to calculate current MCC value μ1. If μ1 < μ0,
the filtering can stop as the performance with the
reduced gene set is worse than the performance before
the genes reduction. If μ1 > μ0, it is necessary to further
reduce the number of irrelevant genes and we perform a
second round filtering by repeating the procedures in
5.1 with data from these G1 genes.
In general, after each round of filtering, we calculate
the cross validated MCC performance for SVM using all
the genes kept at the end of previous round filtering. If
the new MCC value is greater than the previous MCC
value, the filtering continues to the next round. Other-
wise, the filtering stops.
The number of random combinations K (i.e., the row
dimension of X) should not be too small such that
enough cases of interaction of a gene with other genes
can be considered. The K is taken to be 500 for the first
round filtering, 450 for the second round, 400 for the
third round, etc. and the lower bound for K is 300. For
the colon cancer dataset (Alon et al., 1998), we per-
formed fifteen rounds of filtering with K=500, 450, 400,
350 for the first four rounds, and K=300 for the
remaining eleven rounds. The total number of SVM
models trained is equal to 502 +451 +401 +351 +301
x11 = 5016 , among which 5001 models are support vec-
tor classification with sample size being the same as the
number of original sample, and 15 models are support
vector regression with sample sizes being in the range of
500 to 300. Only 7 genes are kept after the 15 rounds of
filtering. These 7 genes can be studied in detail for fine
evaluation. Setting K gradually decreasing corresponds
to the reduced number of independent variables in the
model as the variable elimination continues because less
numbers of combinations are needed. This will make the
program run faster and faster as it proceeds.
Iterative filtering is also used in the random forest fea-
ture selection algorithm of Díaz-Uriarte and Alvarez de
Andre’s (2006). Fitting one subspace decision tree may
take less time than one round of our filtering, but the
number of trees in each decision forest required to have
stable values of variable importance is in the magnitude
of 2000 to 5000 (Díaz-Uriarte and Alvarez de Andre’s
2006; [25]). In addition, the percent of features to be
eliminated from each decision forest is a parameter that
requires user’s input. The default percentage in Díaz-
Uriarte and Alvarez de Andre’s (2006) is set to be 20%,
which eliminates 20% of the features from each fitted
decision forest. Since each decision forest is restricted in
a subspace, the total number of iteratively fitted decision
forests is very large in order to eliminate majority of fea-
tures. On the other hand, our algorithm starts with all Gfeatures and eliminates about half on each round of fil-
tering. So the total number of rounds is about log2(G),
which is much smaller than the number of decision for-
ests that need to be fitted.Fine evaluation of candidate genes retained from earlier
filtering
After the filtering procedure in 5.1 – 5.2, the number of
genes has been dramatically reduced. In the 9 datasets
we considered, the number of retained genes is 20 or
less for 8 of the datasets. The remaining dataset had 36
genes retained. For these small numbers, fine evaluation
of each gene taking into account its interaction with
other genes can be performed more accurately. We per-
form the following backward elimination procedure to
achieve this goal. Initialize Ω to be the collection of all
genes retained after the filtering in 5.1 – 5.2. Ω will be
updated as the algorithm below proceeds.
(a) Denote k to be the number of candidate genes in Ω.
(b)With all k candidate genes in Ω, obtain the MCC
value with 10-fold CV using support vector
machine classification. Denote the MCC value as
Ø(k).
(c) Leave out the ith gene and use the remaining k-1
genes in 10-fold CV with SVM classification to
obtain the Matthews correlation coefficient Ø-i.
Perform this for all i=1, 2, . . ., k.
(d) If max{Øi, 1≤ i ≤ k} <Ø
(k), skip e) and f) and go to
step g).
(e) Let j be the gene in the candidate list in Ω such that
Ø-j = max{Ø-i, 1≤ i ≤ k}. Remove the j
th gene from
the candidate list Ω and change the variable k to
have value k-1.
(f ) Repeat a) – e).
(g) Report all the genes that are in Ω. These are the
final list of informative marker genes to be used for
cancer classification.
The stopping criterion in (d) sometimes may produce
some unnecessary computation when max{Ø-i, 1≤ i ≤ k}
and Ø(k) are very close. An alternative is to treat the
number of features in the final classifier as a tuning par-
ameter or simply define a threshold of the importance
for the purpose of feature selection. For example, the en-
tire fine evaluation step can be replaced with SVM-RFE,
in which the number of features in the final classifier
will be left as a tuning parameter. This alternative direc-
tion may be able to speed up the fine evaluation process.
But adding additional tuning parameter also raises a
question of how to estimate this parameter. It is an open
question and additional study will be required to evalu-
ate how well it works.
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genes
Relative importance of each informative gene in the final
list can be further ordered through multi-round elimin-
ation. Denote k0 as the number of selected informative
genes in the final list.
(i) Let m = k0 and define a buffer set ß that contains
all genes to be ordered. The initial members of ß
contain all genes in the final list. Initialize М to be
a null vector to store the genes in the order of
importance.
(ii) For t=1, . . ., m, remove the tth gene in ß and use
the remaining m-1 genes in 10-fold CV with SVM
classification to obtain the Matthews correlation
coefficient Ø-t. Perform this for all t=1, 2, . . ., m.
(iii) Let q be the gene in ß such that Ø-q = maxØt, 1≤ t
≤ m}. Remove the qth gene from ß and make it the
first element of М by shifting the other elements in
М accordingly. Change variable m to have value m-
1.
(iv) Repeat steps (i) – (iii) until only one gene is left in
ß. Move this gene to М so that this gene is the first
element in М and other genes are shifted
accordingly.
At the end of step (iv), the genes in М are ordered.
The most important gene is the first element in М and
the importance of other genes reduces as the position of
a gene moves upward.
Alternatively, it might be desirable to give the signifi-
cance of the selected genes. This can be achieved with
the procedure in I) – IV) below.
(I) If the number of informative genes k0 is no more
than 9, we can consider all combinations of the
informative genes and form a matrix X0 with k0
columns and 2k0 rows. The elements of X0 are
zeros or ones indicating whether the genes
designated by the column numbers are excluded
or not for modeling. The total number of rows is
no more than 29 =512.
(II) If the number of informative genes k0 is more than
9, we generate a matrix X with K rows and k0
columns using these k0 genes as described in Step
1 of Section 5.1.1. Further, append X with
additional k0+1 rows, the first of which is
composed of all ones and the last k0 rows form an
identity matrix. Denote the resulting (K+ k0+1) by
k0 matrix as X0.
(III) Perform Steps 2 and 3 of Section 5.1.1 using
matrix X0 with the original expression data for all
the k0 informative genes and class labels for all
subjects. By the end of this operation, paired dataZ0 and Zi are obtained for each informative gene,
one representing prediction performances without
this gene, and the other one representing the
performances with the gene while all other
informative genes are considered in the modeling.
(IV) For each informative gene, carry out a paired t-test
using the paired data obtained in III) and report
the p-value.
Each row of the identity matrix appended to X in II)
serves as a univariate evaluation of the contribution of each
gene. Such evaluation ignores the possible co-regulation of
genes and their interactions. Consequently, they can only
be used along with combinations of other genes provided
by other rows of X to give a fair evaluation of each gene’s
contribution.
The entire procedure described in 5.1 – 5.3 uses the
Matthew’s Correlation Coefficient of SVM as the object-
ive function to guide the search for optimal gene set.
We have avoided the computational infeasibility asso-
ciated with exhaustive search by repeatedly considering
random combinations of genes. As the support vector
machine is the tool to study the relationship between
the class labels and the informative genes, the possible
nonlinear dependence on each gene and its interaction
with other genes are captured. The evaluation process
described in section 5.3 may employ a different classifier
since the number of informative genes tends to be small
at that stage. However, the process in earlier sections re-
lies on a classifier that is able to handle a large number
of independent variables. K-nearest neighbor (KNN) al-
gorithm also can perform classification with a large
number of independent variables. However, since this al-
gorithm barely differentiates among different genes in
the sense that each gene in the nearest neighborhood of
a point contributes equally in making class assignment,
we prefer not to use KNN to guide the search.
Software and Data
The BMSF Matlab code used in this article and the data
sets with the selected genes are available in the zipped file
Additional file 2. The NCBI links for the 9 cancer datasets
used in this article are also given in this zipped file.
Additional files
Additional file 1: This file contains Supplementary Tables S1 - S4.
Supplementary Table S1 reports the Accession number, name, and putative
function for selected genes in each data set. Supplementary Table S2 gives the
comparison of LOOCV accuracy on nine cancer data sets for BMSF with results
reported in literature. Supplementary Table S3 list the selected genes from 30
separate runs of BMSF on Leukemia data. Supplementary Table S4 reports the
LOOCV accuracy of BMSF, random forest (GeneSrF), SVM-RFE, and 11 other
variable selection criteria from RankGene and mRMR. The same number of
genes (determined by BMSF) is used for all criteria except for random forest,
which automatically determines the number of genes to be used.
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